53907 Amlitelimab Improves Extent and Severity of Disease in Adults with Moderate-to-severe Atopic Dermatitis (AD): 24-Week Results from a Phase 2b Trial (STREAM-AD)
Journal of the American Academy of Dermatology（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要